New Research Poster Presentation 5.32
A New Formulation of Methylphenidate: Phase 3 Study of the Efficacy and Tolerability of an Extended-Release Orally Disintegrating Tablet in Children 6-12 Years of Age With ADHD
A New Formulation of Methylphenidate: Phase 3 Study of the Efficacy and Tolerability of an Extended-Release Orally Disintegrating Tablet in Children 6-12 Years of Age With ADHD
Friday, October 30, 2015 12:30 PM